Clinical trialNCT01436500CompletedPhase 2Interventional

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

SponsorCumberland PharmaceuticalsEnrollment55Hepatorenal Syndrome

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A study of ifetroban in the treatment of hepatorenal syndrome (HRS) in hospitalized adult patients to assess the safety and pharmacokinetics of 3 days of intravenous ifetroban.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Brendan McGuire, MD
University of Alabama at Birmingham
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

India

Midas Multispeciality Hospital Pvt Ltd
Nagpur, Maharashtra, India

United States

Mayo Clinic - Arizona
Phoenix, Arizona, United States
Ucsd, Hillcrest Medical Center Hospital
La Jolla, California, United States
Ucsf (university of California-San Francisco)
San Francisco, California, United States
Emory University Hospital
Atlanta, Georgia, United States
Indiana University (division of Gastroenterology/hepatology)
Indianapolis, Indiana, United States
University of Michigan Hospital
Ann Arbor, Michigan, United States
Nyu Langone Medical Center
New York, New York, United States
the Ohio State University
Columbus, Ohio, United States
Baylor All Saints Medical Center
Fort Worth, Texas, United States
University of Utah Health Sciences Center
Salt Lake City, Utah, United States
Virginia Commonwealth University
Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

IfetrobanPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2011
Primary completion: 30 Jun 2015
Completion: 31 Jul 2015
Last update posted: 1 Mar 2017
Registered enrollment: 55
Registry id: NCT01436500

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.